Live Breaking News & Updates on Medical Oncology Breast Cancer Congress

Stay updated with breaking news from Medical oncology breast cancer congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fertility Treatment Safe for Breast Cancer Survivors With BRCA Mutations

No significant increased risk of recurrence or pregnancy complications ....

United States , Janice Tsang , Matteo Lambertini , Mike Bassett , University Of Hong Kong , European Society For Medical Oncology , University Of Genova , San Martino Hospital , European Society , Medical Oncology Breast Cancer Congress , Hong Kong ,

Atezolizumab Plus Chemo Falters in Rapidly Relapsing TNBC

No difference in survival versus chemotherapy alone in patients with PD-L1-positive disease ....

Dana Farber Cancer Institute , United States , Saram Tolaney , Mike Bassett , National Cancer Center Singapore , European Society , Medical Oncology Breast Cancer Congress ,

ER-low Expressors Experience Benefit With Trastuzumab Deruxtecan in DESTINY-Breast04 Subgroup Analysis

Fam-trastuzumab deruxtecan-nxki was associated with better efficacy outcomes compared with treatment of physician’s choice in patients with HER2-low, estrogen receptor-low metastatic breast cancer, according to findings from a subgroup analysis of the phase 3 DESTINY-Breast04 study. ....

City Of , United Kingdom , Davida Cameron , Breast Cancer Congress , University Of Edinburgh , Cancer Congress , New England Journal , Medical Oncology Breast Cancer Congress , Esmo Breast Cancer Virtual Meeting , Breast Cancer ,

Abemaciclib Is Associated With a Manageable Safety Profile in Early HR+/HER2- Breast Cancer

Adjuvant abemaciclib with endocrine therapy led to a tolerable safety profile in patients with hormone receptor-positive, HER2-negative, node-positive, high-risk, early breast cancer, ....

Daiichi Sankyo , Nadia Harbeck , Breast Centre , University Of Munich , Aptitude Health , Medical Oncology Breast Cancer Congress , Conservative Oncology , Esmo Breast Cancer Virtual Meeting , Breast Cancer ,

Antibody-Drug Conjugate Promising for Breast Cancer With Brain Mets

High intracranial response rates with trastuzumab-deruxtecan observed in TUXEDO-1 trial ....

United States , Comunidad Autonoma De Cataluna , Rupert Bartsch , Mike Bassett , Mafalda Oliveira , Hebron University Hospital , Breast Cancer Congress , University Of Vienna , Medical University , European Society , Medical Oncology Breast Cancer Congress ,